Daiichi Suntory Pharma (Rights To 6R-BH4) is Buildings and Property in Japan that focus on drug development business. They cover business area such as a drug development, marketing, Japan, cardiovascular indication, genetic disease phenylketonuria, PKU.
-
Drug Development
-
Daiichi Sankyo Building A/B 3-5-1
Nihonbashi-honcho
Tokyo, 103-8426
Japan
Private
a drug developmentmarketingJapancardiovascular indicationgenetic disease phenylketonuriaPKU
* We use standard office opening hours in near Daiichi Suntory Pharma (Rights To 6R-BH4)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Daiichi Suntory Pharma (Rights To 6R-BH4) is Buildings and Property business from Japan that founded in - ( years old in ), Daiichi Suntory Pharma (Rights To 6R-BH4) business is focusing on Drug Development.
Daiichi Suntory Pharma (Rights To 6R-BH4) headquarter office and corporate office address is located in Daiichi Sankyo Building A/B 3-5-1 Nihonbashi-honcho Tokyo, 103-8426 Japan.
Daiichi Suntory Pharma (Rights To 6R-BH4) was founded in Japan.
In , Daiichi Suntory Pharma (Rights To 6R-BH4) is currently focus on drug development sector.
Above is snippet of Google Trends for "drug development" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Daiichi Suntory Pharma (Rights To 6R-BH4), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
